Pacira BioSciences
PCRX
PCRX
218 hedge funds and large institutions have $1.86B invested in Pacira BioSciences in 2019 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 54 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
+8
Holders Change %
+3.81%
% of All Funds
4.74%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
40
Increased
85
Reduced
54
Closed
30
Calls
$9.61M
Puts
$7.85M
Net Calls
+$1.77M
Net Calls Change
-$2.46M
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
+$37.9M |
| 2 |
PC
Paulson & Co
New York
|
+$30.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$23.1M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$19.7M |
| 5 |
Millennium Management
New York
|
+$17M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$40.8M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$37.1M |
| 3 |
HM
HealthCor Management
New York
|
-$26.9M |
| 4 |
Goldman Sachs
New York
|
-$12.9M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$6.94M |
